Health ministry in talks to shield India’s pharma industry amid impending tariffs from team Trump

India's health ministry is actively exploring strategies to protect its pharmaceutical industry from potential US tariffs. Discussions involve a fixed tariff regime and waiving import tariffs on US pharma products. The US is also raising concerns about nutraceutical imports, prompting India to consider regulatory changes, potentially impacting the nutraceutical market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GFvdisJ
via IFTTT